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This chapter is important and hence we felt that some general information has to be given
globally on the physiological research, as we could not do a detailed study being interns in the
medical department of the medical services.
We met the presentations of these new results at different times in our life, which modified
our aims and possibilities in the research. On the other hand, our lifes gave to us a possibility
to our scientific and methological konowledges to incorporate these new fields in our research
field.
We have to learn the following:
1. Being clinicians, our main work is related to the medical service of patients’ problems;
however, we wanted to learn the main biochemical events in the gastrointestinal tract (in
terms of development of mucosal damage and prevention);
2. We started with the biochemical examinations of gastric tissues from 1960s, and these new
observations offered us to do the forthcoming steps in our research work;
3. We had time periods in our lifes when we had contamining (infecting) with basic and
fruitful international research lines , when we had opportunities to participate and to work
in research of different foreign countries (GyM in Norway in 1968–1969 and USA in 1985;
IL Szabo in USA in 1999–2001);
4. We learned new research methods while working with foreign countries, and we tried to
apply the new knowledge in researches that we did in our country (Hungary);
5. It was very clear that there is a big gap between the problems (results) of a basic research
and clinical practice; however, we wanted to understand the main common problems in
the basic research and in clinical science;
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6. We had many ethical and medical problems in doing biochemical observations in the
gastrointestinal resecates of human GI tract in patients with peptic ulcer who underwent
surgical interventions owing to their primary disease;
7. We participated in the different international forums of GI research (as established
persons, future leaders, organizers and responsible persons).
Our main lines of research series of international conferences are as follows:
a. An international series of international conferences [International Conference of Experi‐
mental Ulcer (from 1970 to 1994), International Conference on Ulcer Research (from 1994
to 2000) and International Conference on Gastrointestinal Research (from 2000)] has been
internationally established at Copenhagen (Denmark) – in connection with Fourth World
Congress of Gastroenterology – in 1970. Thereafter, different international conferences
were organized in different countries of different continents (Copenhagen, Denmark,
1970; Cologne, Germany, 1972; Parádfürdő, Hungary, 1976; Tokyo, Japan, 1980; Boston,
USA, 1985; Jerusalem, Israel, 1988; Berlin, Germany, 1991; Kyoto, Japan, 1994; Hong Kong,
China, 1997; Budapest-Pécs, Hungary, 2000; Dubrovnik, Croatia, 2003; Osaka, Japan, 2006;
Split, Croatia, 2009; Tokyo, Japan, 2012) (for details, see Mózsik, 2006b);
b. Another series of international symposiums was established in connection with main
World Congresses of the International Union of Pharmacology (from 1984). The gastro‐
intestinal section of International Union of Pharmacology was established at Montreal
(Canada) in 1994 (IUPHAR GI Section); however, this series of the international sympo‐
siums started earlier (Pécs, Hungary, 1984; Pécs, Hungary, 1990; Pécs, Hungary, 1995;
Sperlonga, Italy, 1996; Pécs, Hungary, 1998; Honolulu, USA, 2002; Kyoto, Japan, 2004;
Osaka, Japan, 2006; Honolulu, Hawaii, USA, 2009; Tokyo, Japan, 2012) (for details, see
Mózsik et al., 2006);
c. International Symposia on “Cell/Tissue Injury and Cytoprotection/Organoprotection”
[Heidelberg, Germany, 1986; Boston, USA, 1989; Long Beach, CA, USA, 2000; 2006; Yalta
(Crimea), Ukraine, 2008; Saint Petersburg, Russia, 2011; Honolulu, USA, 2012; Budapest,
Hungary, 2014];
d. International Symposia on Gastrointestinal Cytoprotection (Pécs, Hungary, 1983; 1987;
1991; 1995, 2000);
e. International Symposia of the “International Brain-Gut Society” (Lake Arrowhead, Los
Angeles, USA, 1988; Pécs, Hungary, 1990; Florence, Italy, 1993; Pécs, Hungary, 1995);
f. Interscience World Conferences on Inflammation [Antirheumatics, Analgesics, Immuno‐
modulators (Venice, Italy, 1984; Monte Carlo, France, 1986; 1989; Geneva, Switzerland,
1995; 1998)].
8. This part of the book has been tried to give a short information on the different membrane-
bound ATP-dependent energy systems with emphasizing the main problems in these
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fields, however in briefly up to now (we had no these summaries of these studies in our
mind during the time of our observations done in GI tract).
We have to emphasize that we have not done a very detailed study on the membrane-bound
ATP-dependent energy systems; however, the results of our study (namely the study of the
details of ATP splitting by different membrane-bound enzymes, Na+–K+-dependent ATPase
and adenylate cyclase, represent different pathways of energy-liberating cellular events)
offered us a very successful research possibility in our field. As ATP splitting results in energy
liberation of cells, and the circumstances of the ATP resynthesis (by oxidative phosphorylation)
confirmed the presence of tissue hypoxia in the GI mucosa under different (e.g., in the ulcerated
or the damaged mucosal tissues) experimental and clinical circumstances.
The main lines of the studies on membrane-bound ATP-dependent energy systems were
carried dominantly from GI tract, except for H+–K+-ATPase system (we did not participate in
these studies), and hence we started with these studies in our field. Furthermore, these studies
offered good possibility to understand the presence of tissue hypoxia (anoxia) during the
development of mucosal damage, which was suggested as one of the main reasons (or
consequences) of peptic ulcer.
Before the demonstrations of our biochemical results, we will give a very short summary of
the main membrane-bound ATP-dependent energy systems (of course, not in the gastric
mucosa).
5.1. Na+-K+dependent ATP-ase
This enzyme (other names: sodium–potassium adenosine triphosphatase, Na+/K+ pump,
sodium–potassium pump, sodium pump) is located in the plasma membrane of all animal
cells. The Na+-–K+-ATPase enzyme pumps sodium out of the cells, while pumping potassium
into the cells.
Active transport is responsible for cells containing relatively high concentrations of potassium
ions but low concentrations of sodium ions. The mechanism responsible for this sodium-
potassium pump moves these two ions in opposite directions across the plasma membrane.
This was investigated by following the passage of radioactive ions across the plasma mem‐
brane of certain cells. It was found that the concentrations of sodium and potassium ions on
the two sides of the membrane are independent, which suggests that the same carrier trans‐
ports both ions. It is now known that the carrier is an ATPase and it pumps three sodium ions
of the cell for every two potassium ions pumped in.
The sodium–potassium pump was discovered in the 1950s (Skou, 1957) by Jens Christian Skou
(Department of Physiology, Aarhus University, Denmark), who was awarded Nobel Prize in
chemistry in 1997 (http://nobelprize.org/chemistry/laureates/1997/index.html). It marked an
important step forward in our understanding of how ions get into and out of cells, and it is
particularly significant for excitable cells such as nervous cells, which depend on this pump
for responding to stimuli and transmitting impulses (Skou, 1965).
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5.1.1. Schematic morphological bases of sodium-potassium pump (Na+-K+-dependent adenosine
triphosphatase enzyme)
The Na+–K+-ATPases belong to the P2 class and specifically to the P2c subclass of ATPases. These
ATPases are composed of two subunits (α and β). The α-subunit (about 113 kD) binds ATP
and both Na+ and K+ ions and contains the phosphorylation sites typical of the P-type ATPases.
The autophosphorylation site is the P domain. The P-type ATPases are also subject to addi‐
tional phosphorylation events via other kinases. The smaller β-subunit (about 35-kD glyco‐
protein) is absolutely necessary for activity of the complex. It appears to be critical in facilitating
the plasma membrane localization and activation of the α-subunit.
Several isoforms of both α- and β-subunits have been identified that exhibit different kinetic
parameters and tissue distribution. There are four α-subunit genes and three β-subunit genes
in humans. The α1 isoform is the predominant form and is ubiquitously expressed. The α2
isoform is primarily expressed in muscle tissues (skeletal, smooth and cardiac) as well as in
adipose tissue, brain and lungs. The α3 isoform is expressed primarily in the heart and neurons.
The α4 isoform is only expressed in the testes. The β1 isoform is ubiquitously expressed and is
associated with the α-subunit in the ubiquitously expressed α1 β1 Na+–K+-ATPase complex.
There are many more detailed parts and interactions of Na+–K+-ATPase discovered and proved
in the last decades (http://themedicalbiochemistrypage.org/membranes.php; Morth et al.,
www.nature.com/reviews/molcellbio 12:60–70, 2011).
5.1.2. Main functions of Na+-K+-ATPase
The Na+–K+-ATPases help to maintain resting potential and regulate cellular volume (Hall and
Guyton, 2006). It also functions as signal transducer/integrator to regulate the mitogen-
activated protein kinase (MARK) pathway, mitochondrial reactive oxygen species (ROS) as
well as intracellular calcium. In most animal cells, the Na+–K+-ATPase is responsible for about
1/5 of the cell’s energy expenditure, meanwhile, for neurons, the Na+–K+-ATPase can be
responsible for up to 2/3 of the energy expenditure (Howard et al., 2012).
5.1.2.1. Resting potential
In order to maintain the cell membrane potential, cells keep a low concentration of sodium
ions and high levels of potassium within the cell (intracellular). The sodium–potassium pump
moves three sodium ions out and moves two potassium ions in, thus in total removing one
positive-charge carrier from the intracellular space.
5.1.2.2. Transport
Export of sodium from the cell provides the driving force for several secondary active
transporters, membrane transport proteins, which import glucose, amino acids and other
nutrients into the cell by the use of sodium gradient.
Another important task of the Na+–K+-pump is to provide a Na+ gradient that is used by certain
carrier processes. In the gut, sodium is transported out of the reabsorbing cell on the blood
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(intestinal fluid) side via the Na+–K+-pump, whereas, on the reabsorbing (luminal) side, the Na
+-glucose symporter uses the created Na+ gradient as a source of energy to import both Na+
and glucose, which is far more efficient than simple diffusion. Similar processes can be found
and located in the renal tubular system.
5.1.2.3. Controlling cell volume
Failure of the Na+–K+ pumps can result in swelling of the cell. A cell’s osmolarity is the sum of
the concentrations of the various ion species and many proteins and other organic compounds
inside the cell. When this is higher than the osmolarity outside of the cell, water flows into the
cell through osmosis. This can cause the cell to swell up and lyze. The Na+–K+ pump helps to
maintain the right concentrations of ions. Furthermore, when the cell begins to swell, this
automatically activates the Na+–K+ pump.
Within the last decade, many independent laboratories have demonstrated that, in addition
to classical ion transporting, this membrane protein can relay extracellular ouabain-binding
signaling into the cell through regulation of protein tyrosine phosphorylation. The down‐
stream signals through ouabain-triggered protein phosphorylation events include activation
of the mitogen-activated protein kinase (MARK) signal cascades, mitochondrial reactive
oxidative species (ROS) production, as well as activation of phospholipase C (PLC) and inositol
triphosphate (IP3) receptor (IP3R) in different intracellular compartments (Yuan et al., 2005).
Protein–protein interactions play a very important role in Na+–K+ pump-mediated signal
transduction (e.g., Na+–K+ pump interacts directly with Scr, a non-receptor tyrosine kinase) to
form a signaling receptor complex (Tian et al., 2006). Scr kinase is inhibited by Na+–K+ pump,
while, upon ouabain binding, the Scr kinase domain will be released and then activated. Based
on this scenario, NaKtide, a peptide Scr inhibitor derived from the Na+–K+ pump, was
developed as a functional ouabain-Na+–K+ pump-mediated signal transduction (Li et al., 2009;
Forrest et al., 2012; Cannon, 2004; Calderon et al., 2011; Young et al., 2008).
5.1.3. Main steps of mechanism
The following main steps are involved in the mechanism:
• The pump, while binding ATP, binds three intracellular Na+ ions (Hall and Guyton, 2006);
• ATP is hydrolyzed, leading to phosphorylation of the pump at a highly conserved aspartate
residue and subsequent release of ADP;
• A conformational change in the pump exposes the Na+ ions to the outside. The phosphory‐
lated form of the pump has a low affinity for Na+ ions, so they are released;
• The pump binds two extracellular K+ ions. This causes the phosphorylation of the pump,
reverting it to its previous state, transporting the K+ ions into the cells;
• The unphosphorylated form of the pump has a higher affinity for Na+ ions than K+ ions, so
two bound K+ ions are released. ATP binds and the process starts again.
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Figure 21. Schematic representation of the sodium pump (Na+–K+ ATPase): flow of ions (http://
enzyme.expasy.org/EC/3.6.3.9).
Figure 22. Schematic representation of the sodium pump (Na+–K+ ATPase): alpha and beta units (http://enzyme.expa‐
sy.org/EC/3.6.3.9).
The function of Na+–K+ pump can be regulated endogenously and exogenously.
The Na+–K+ pump is upregulated by cyclic adenosine monophosphate (cAMP) (Bunnier 2008).
Thus, substances causing an increase in cAMP level upregulate the Na+–K+ ATPase. These
include the ligands of the Gs-coupled GPCRs. In contrast, the substances causing a decrease in
cAMP downregulate the Na+–K+-ase. These include the ligands of Gi-coupled GPCRs.
The ouabain (as cardiac glycoside) inhibits the Na+–K+ ATPase activity. The prove the presence
of ouabain inhibition of different preparates of plasma membranes was one of the most criteria
to indicate presence a good Na+-K+-dependent ATPase.
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5.2. The gastric H+- K+-ATP-ASE
The gastric hydrogen potassium ATPase or H+/K+-ATPase is the proton pump of the stomach
and hence it is the enzyme primarily responsible for the acidification of the stomach (acid
secretion) (Potassium Hydrogen ATPase (https://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?
mode= &term=Potassium +Hydrogen+ ATPase).
The H+–K+- ATPase is found in the parietal cells, which are highly specialized epithelial cells
located in the inner cell lining of the stomach called gastric mucosa. Parietal cells process an
extensive secretory membrane system and the H+–K+-ATPase is the major protein constituent
of these membranes.
The enzyme that keeps the stomach at pH 0.6:
• The parietal cells of the gastric mucosa (lining of the stomach) have an external pH of 7.4;
• H+–K+-ATPase pumps protons from these cells into the stomach (using energy of ATP) to
maintain a pH difference across a single plasma membrane of 6.6;
• This is the largest known transmembrane gradient in eukaryotic cells.
5.2.1. The gastric H+-K+-ATPase can be characterized by the followings
• H+–K+-ATPase is similar in many respects to Na+–K+-ATPase and Ca2+-ATPase;
Figure 23. Schematic representation of the sodium pump (Na+–K+ ATPase), E2-Pi state. Calculated hydrocarbon boun‐
daries of the lipid bilayer are shown as blue (intracellular) and red (extracellular) planes (http://
enzyme.expasy.org /EC/3.6.3.9).
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• All three enzymes form covalent E–P intermediates (P-type pumps);
• All three have similar sequences for the large (α) subunit;
• All three are involved in active transport.
The H+–K+-ATPase is a heterodimeric protein, the product of two genes. The gene ATP4A
encodes the H+–K+-ATPase α-subunit and is about 1000 amino acid protein that contains the
catalytic sites of enzyme and forms the pore through the cell membrane that allows the
transport of ions.
The gene ATP4B encodes the β-subunit of the H+–K+-ATPase, which is about 300-amino acid
protein with a 36 –amino acid N-terminal cytoplastic domain, a single transmembrane domain
and a highly glycosylated extracellular domain. The H+–K+-ATPase β-subunit stabilizes the H
+–K+-ATPase α-subunit and is required for function of the enzyme. It also appears to contain
signals that direct the heterodimer to membrane destinations within the cell, although some
of these signals are subordinate to signals found in H+–K+-ATPase α-subunit.
The H+–K+-ATPase is a member of the P-type ATPase superfamily, a large family of related
proteins that transport ions, usually cations, across biological membranes of nearly all species.
Figure 24. Schematic surface representation of gastric H+–K+‐ATPase αβ‐protomer with the fit homology model in rib‐
bon representation. Color code of the density map: N domain, green; A domain, cyan; P domain, yellow; TM domain
of the α‐subunit, wheat; β‐subunit, magenta. Color code of the homology model: N, A and P domains have the same
color as the density map; TM helices M1–M10 of the α‐subunit, gradual change from M1 (blue) to M10 (red); TM helix
of β‐subunit, white. The dotted lines indicate the probable position of the lipid head group and result in total thickness
of approximately 35 Å, which is based on the densities protruding perpendicular from the TM domain (arrowheads).
The bound ADP and AlF4 molecules are shown as red sphere.
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The H+–K+-ATPase transports one hydrogen ion (H+) from the cytoplasm of the parietal cell in
exchange for potassium (K+) retrieved from the gastric lumen. As an ion pump, the H+–K+-
ATPase is able to transport ions against a concentration gradient using energy derived from
the hydrolysis of ATP. Like all P-type ATPases, a phosphate group is transformed from
adenosine triphosphate (ATP) to the H+–K+-ATPase during transport cycle. This phosphate
transfer powers a conformational change in the enzyme that helps drive ion transport (Yao
and Forte, 2003; Kühlbrandt, 2004; Dunbar and Caplan, 2001; Sachs et al., 1995) (http://
www.mlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&term=Potassium+Hydrogen+ATPase).
The Na+–K+-ATPase and H+–K+-ATPase indicate some similarities in the structural building of
these enzymes; however, they can be separated from each other by using immunological
methods (Stoll and Berglinch, 1987; Sachs, 1987; Chang et al., 1977; Faller et al., 1982; Ganser
and Forte, 1973; Lee et al., 1974; 2001; Maclennan et al., 1985; Saccomani et al., 1979 a, b; Sachs,
1977; Sachs et al., 1972; 1980; 1995; Shull et al., 1985; Koenderink et al., 1999; Asano et al., 2003).
5.3. Adenylate cyclase
5.3.1. Short historic background
Sutherland (1951) studied how the hormone epinephrine (adrenaline) signals to regulate the
degradation of glycogen to glucose in the liver, thereby increasing glucose output into the
blood, so that an organism can respond to stress. He worked alongside future Nobel Prize
winners Edmond Fishers and Edwin Krebs, who demonstrated that adenosine triphosphate
(ATP) and magnesium were required for phosphorylase activation. Sutherland (1953) agreed
to be the chairman of the pharmacology department of Case Western Reserve University in
Cleveland and was joined by Theodore R. Rall, “marking the beginning of a long and fruitful
period of collaboration between us” [Sutherland EW. Studies on the mechanism of hormone.
Science 177: 401–408, 1972 (Lecture delivered 11 December 1971 when he received the Nobel
Prize in Physiology or Medicine)]. Sutherland and Rall discovered that epinephrine works by
stimulating another chemical messenger, the enzyme glycogen phosphorylase, to begin the
sugar-releasing process in the cells (Henion and Sutherland, 1955). This stimulation occurs by
means of an intermediary that Sutherland called it the “second messenger,” which he identified
as a nucleotide and named cyclic AMP (Sutherland et al., 1957; Sutherland and Rall, 1957; Rall
and Sutherland, 1957; 1958; Butcher and Sutherland, 1962; 1965; Klainer et al., 1962; Murad et
al., 1962). As early as 1960, Sutherland suggested that cyclic AMP acts as a “second messenger”
for other hormones as well (Sutherland and Rall, 1958) (for other summaries, see Butcher, 1966;
Sutherland, 1962; Sutherland and Rall, 1960; Sutherland et al., 1962; Sutherland and Robison,
1966; Andrási, 1997).
Practically at the same time, the discovery of cyclic 3’-5’-AMP appeared in the organ pharma‐
cology (Sutherland et al., 1965; 1968).
The adenylate cyclase is an enzyme with key regulatory roles in essentially all cells. It is the
most polyphyletic known enzyme: six district classes have been described, all catalyzing the
same reaction, but representing unrelated gene families with no known sequence or structural
homology (Class I AC, Class II AC, Class III AC, Class IV AC, Class V AC and Class VI AC).
Membrane-bound ATP-dependent Energy Systems (A Short Historic View from...
http://dx.doi.org/10.5772/60100
65
The Classes AC I (E. coli), II (Bacillus anthracis and Bordetella pertussis), IV (Aeromonas
hydrophyla, Yersinia pestis), V and VI (Prevotella ruminicola and Rhizobium etli) are present
in different bacteria. The best-known AC class is class III or AC-III (Roman numerals are used
for classes). The AC-III occurs widely in eukaryotes and has important roles in many human
tissues.
All classes of AC catalyze the conversion of ATP to 3’,5’-cyclic adenosine monophosphate
(cAMP) and pyrophosphate. Divalent cations (usually Mg2+) are generally present in the
enzymatic mechanism. The cAMP produced by AC then serves as regulatory signal via specific
cAMP-binding proteins, either transcription factors or other enzymes (e.g., cAMP-dependent
kinases).
Most AC-IIIs are integral membrane proteins involved in transducing extracellular signals into
intracellular responses. A Nobel Prize in physiology (medicine) was awarded to Earl W.
Sutherland (Department of Physiology, Vanderbilt University, Nashville, TN, USA) in 1971
for discovering the key role of AC-III in human liver, where adrenaline directly stimulates AC
to mobilize stored energy in the “fight or flight” response (Robinson GA, Butcher RW,
Sutherland EW: Cyclic AMP. Academic Press, New York and London, 1971) (two papers
published by myself – Mozsik G.: Eur. J. Pharmacol 7: 319, 1969 and in 9: 107, 1970 – were cited
by the authors in this book).
The effect of adrenaline is via a G protein-signaling cascade, which transmits chemical signals
from outside the cell across the membrane to the inside of the cell (cytoplasm). The outside
signal (in this case, adrenaline) binds to a receptor, which transmits a signal to the G protein,
Figure 25. Schematic representation of adenylate cyclase location in the plasma membrane and main steps of intracel‐
lular regulatory pathways (http://www.cs.stedwards.edu/chem/Chemistry/ CHem43/).
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which transmits a signal to adenylate cyclase, which transmits a signal by converting adeno‐
sine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). Cyclic AMP is known
as the so-called “second messenger” (Reece and Campbell, 2002).
Adenylate cyclases are often activated or inhibited by G proteins, which are coupled to
membrane receptors, and thus can respond to hormonal or other stimuli. Following the
activation of adenylate cyclase, the resulting cAMP acts as a second messenger by interacting
with and regulating other proteins, such as protein kinase A and cyclic nucleotide-gated ions
channels.
AC-III structure:
Most class-III adenylate cyclases are transmembrane proteins with 12 transmembrane
segments. The protein is organized with six transmembrane segments, the C1 cytoplasmic
domain, another six membrane segments and then a second cytoplasmic domain called C1
and C2 regions.
The C1a and C2a sub-domains are homologous and form an intracellular “dimmer” that forms
the active site.
There are ten known isoforms of adenylate cyclases in mammals: ADCY1, ADCY2, ADCY3,
ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9 and ADCY10. These are sometimes called
as AC1, AC2, etc., and sometimes Roman numerals are used for these isoforms that all belong
to the overall AC class III. They differ mainly in how they are regulated, and are differentially
expressed in various tissues throughout mammalian development.
Adenylate cyclase AC-III regulation:
Adenylate cyclase is dually regulated by G proteins (Gs stimulating activity and Gi inhibiting
activity) and forskolin, as well as other isoform-specific effectors:
Isoforms III, V and VIII are also stimulated by Ca2+ /calmodulin;
Isoforms I and VI are inhibited by Ca2+ in a calmodulin-independent manner;
Figure 26. Schematic representation of the structure of adenylate cyclase enzyme (http://enzyme. expasy.org/EC/
4.6.1.1).
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Isoforms II, IV and IX are stimulated by beta–gamma-subunits of the G protein;
Isoforms I, V and VI are most clearly inhibited by Gi, while other isoforms show less dual
regulation by the inhibitory G protein.
Soluble AC (sAC) is not a transmembrane form and is not regulated by G proteins or forskolin,
instead it acts as a bicarbonate/pH sensor. It is anchored at various locations within the cell
and, with phosphodiesterases, forms local cAMP-signaling domain
[(http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&term=Adenylate +cyclase) (http://
proteopedia.org/wiki/index.php/Adenylyl_cyclase)].
5.4. Sodium-pump and second messenger system in the gastrointestinal mucosa
5.4.1. Short personal background
After taking short reviews on these biochemical problems in the nature of living cells, we faced
a unique situation, when one of us (GyM) received a fellowship possibility in the Department
of Pharmacology, University of Blindern, Oslo, in 1968–1969. We encountered these problems
in this Department. Furthermore, I worked together with associate professor Ivar Ǿye, who
spent 4 years in the Vanderbilt University (Department of Physiology) and worked together
with Professor Sutherland on the problems of cyclic AMP.
After returning home (Norway) from USA, Ivar Øye wanted to do his research in the field of
cardiac tissues. He wanted to obtain “plasma membrane” materials, and he wanted to use the
“membrane materials” for the study of pharmacological regulation of cyclic AMP transfor‐
mation in the heart muscles. I was moved to this Department at that time, and I had to receive
the critically good evaluation of action of these drugs, all of those were able to inhibit the
preparations of “membrane materials” from the heart.
I had some methodological knowledge gained from our earlier biochemical studies of the
stomach. However, my new scientific work offered a new challenge in the gastrointestinal
mucosal research.
Furthermore, I had some other affinities to enter into this research field, which are as follows:
a. We earlier mentioned that we were not able to understand and explain the results of
clinical pharmacology in patients with peptic ulcer. This is because most of the researchers
emphasized the key role of vagus nerve (by the increase of gastric acid secretion); thereby
the application of various inhibitory drugs was thought to be reasonable in terms of
decrease of gastric acid production. However, if we evaluated critically the actions of these
drugs, we had to learn that these drugs are able to inhibit the active metabolism in the
gastric tissues. Consequently, we can explain the beneficial effects of these drugs on the
healing of peptic ulcer (which was explained by impaired tissue metabolism).
We concluded that we have to do some change in paradigm of the peptic ulcer research. These
facts and suggestions led us to study the biochemisms in the gastrointestinal mucosa;
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b. Many neural, hormonal (and pharmacological) factors, discovered absolutely new
mechanisms; later, the immunological events could be collected in participation of peptic
ulcer disease. Practically, the researchers studied the influences (action) of one or two
factors (especially HCl and pepsin secretion, mucus secretion, bicarbonate secretion,
prostaglandins, scavengers and antacids, and their different actions) on the stomach
(gastrointestinal tract) in respect to development and protection (healing) of peptic ulcer
disease. The results of these observations reflect only indirectly to the gastrointestinal
tract.
Besides these results, we were uninformed on the biochemical changes in the gastrointestinal
tract in time of gastric acid secretion and mucosal damage versus mucosal protection;
c. We wanted to study the biochemism of gastrointestinal tract, and we suggested that the
final results (and summary) of different etiological factors can modify the functions of
cells in the gastrointestinal tract. The blood supply was a remarkable extracellular factor;
however, the changes in the blood flow also produce significant cellular biochemical
changes in the target organ;
d. A general biochemical approach to study the biochemisms was built up in animal
experiments from 1967. Our biochemical methodologies gave absolutely new insight into
the biochemism of the gastrointestinal tract.
These biochemical observations were done dominantly on pylorus-ligated rats (as in an acute
animal model). One of the most surprising results was to note that similar biochemical changes
were detected in both the rumen and glandular parts (Mózsik et al., 1967 a, b). These results
led us to study the changes in both the parts of the rat stomach after chronic “surgical vagot‐
omy,” chronic atropine treatment and cholinesterase (neostigmine) inhibitor treatments (for
details, refer sections 4.3.1.–4.3.3 of Chapter 4). From the evaluation of the results of clinical
pharmacological studies, we conducted biochemical observations in rats after cessation of drug
(atropine, cholinesterase inhibitor) treatments.
The evaluation of these biochemical results in rats led us to understand some main lines of
cellular biochemistry (cytoplasm, nucleic acids):
a. They were reversible in rat gastric tissues;
b. They were irreversible also.
The first one accepted the metabolic changes in biochemistry and the second one accepted the
metabolic changes in genetic field (nucleic acids). These reversible and irreversible lines in the
biochemical changes especially can be seen during the time of chronic “use” and “disuse” of
vagus nerve. In some observations, we studied the changes of tissue levels of ATP, ADP
(Mózsik et al., 1970a) and base alterations of nucleic acids in the stomach wall after a chronic
atropine treatment (Mózsik et al., 1969b).
The results of these observations opened our eyes to start new observations with the main
cellular functions of cells;
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c. The international discoveries with membrane-bound ATP-dependent energy systems left
a great impression and offered new possibilities to understand the regulations of ATP
splitting and its resynthesis in the cells of the gastrointestinal tract;
d. There was no question that energy liberation exists in all of the functions of membrane-
bound ATP-dependent enzymes (Na+–K+-dependent ATPase, H+–K+-ATPase, adenylate
cyclase). However, the presence of these enzymes was not known in 1968;
e. In my works (in the Department of Pharmacology of Oslo University, Norway), the
biochemical presence of Na+–K+-ATPase was used in my works to prove clearly that we
really work with “membrane preparates,” and these preparates were used to study the
functions of adenylate cyclase. It’s true that my boos wanted to see and to study these
steps in cardiac muscles; however, I used parallelly the gastric mucosa (earlier obtained
in rats, later in human gastric resecates) (Mózsik and Øye, 1969), and we wanted to study
the actions of different drugs (epinephrine, ouabain, NaF ) on the adenylate cyclase. The
NaF was used as the most powerful compound to stimulate the adenylase cyclase, because
it inhibits the activity of all membrane ATPase activity (this fact is well known in the
pertinent literature).
Therefore, consequently, I realized two important things during my study tour in Oslo
(Norway), namely to prepare the adenylate cyclase from the crude “membrane materials”
(from heart muscles and gastric mucosa) and the presence of Na+–K+-ATPase was used as a
chemical marker for the plasma membrane.
We have to emphasize that the presence of neither Na+–K+-ATPase nor adenylate cyclase was
known in animals and especially in humans;
f. I suggested that the functions of these enzymes can be modified by different drugs (not
by only hormones) under different experimental conditions (including the animal
experiments and human medical problems).
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